volibris
glaxosmithkline (ireland) limited - амбрисентан - Хипертония, белодробна - Гипотензивные, - volibris is indicated for treatment of pulmonary arterial hypertension (pah) in adult patients of who functional class (fc) ii to iii, including use in combination treatment (see section 5. efficacy has been shown in idiopathic pah (ipah) and in pah associated with connective tissue disease. volibris is indicated for treatment of pah in adolescents and children (aged 8 to less than 18 years) of who functional class (fc) ii to iii including use in combination treatment. efficacy has been shown in ipah, familial, corrected congenital and in pah associated with connective tissue disease (see section 5.
blokbis 5 mg tablets
actavis group ptc ehf. - Бисопролол - 5 mg tablets
blokbis 10 mg tablets
actavis group ptc ehf. - Бисопролол - 10 mg tablets
blokbis cor 2,5 mg tablets
actavis group ptc ehf. - Бисопролол - 2,5 mg tablets
blokbis cor 5 mg tablets
actavis group ptc ehf. - Бисопролол - 5 mg tablets
blokbis cor 10 mg tablets
actavis group ptc ehf. - Бисопролол - 10 mg tablets
blokbis asa 10 mg/75 mg capsules, hard
10 mg/75 mg capsules, hard
blokbis asa 5 mg/100 mg capsules, hard
5 mg/100 mg capsules, hard
blokbis asa 5 mg/75 mg capsules, hard
5 mg/75 mg capsules, hard